Effect of the Consumption of Alcohol-free Beers With Different Carbohydrates Composition on Postprandial Metabolic Response
1 other identifier
interventional
30
1 country
1
Brief Summary
The overall objective of this study is to explore the glycemic index and glycemic load induced by an alcohol-free beer with modified composition (including almost full fermentation of carbohydrates and the addition of isomaltulose and a resistant maltodextrin), as well as its postprandial metabolic response, compared to the effect induced by: a) an alcohol-free beer with a usual composition; b) an alcohol-free beer with modified composition (including almost full fermentation of carbohydrates and the addition of a resistant maltodextrin). This study includes two cross-over sub-studies recruiting healthy participants. In the first one, 10 healthy volunteers receive 25 g of carbohydrates coming from: regular alcohol-free beer (RB), alcohol-free beer with almost completely eliminated maltose and enriched with isomaltulose (2.5 g/100 mL) and a resistant maltodextrin (0.8 g/100 mL) (IMB), alcohol-free beer with the same maltose removal enriched with resistant maltodextrin (2.0 g/100 mL) (MB) and glucose solution. In the second study, 20 healthy volunteers are provided with 50 g of carbohydrates from white bread and water and the same meal plus 14.3 g of carbohydrates coming from: RB, IMB, MB and extra white bread. Blood is sampled at baseline and for 2 h, every 15 min, after ingestion.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2020
CompletedFirst Submitted
Initial submission to the registry
March 2, 2021
CompletedFirst Posted
Study publicly available on registry
March 10, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2021
CompletedSeptember 30, 2021
September 1, 2021
11 months
March 2, 2021
September 29, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (32)
Glucose
Change from Baseline to 15-minutes after consumption of the beverage.
Glucose
Change from Baseline to 30-minutes after consumption of the beverage.
Glucose
Change from Baseline to 45-minutes after consumption of the beverage.
Glucose
Change from Baseline to 60-minutes after consumption of the beverage.
Glucose
Change from Baseline to 75-minutes after consumption of the beverage.
Glucose
Change from Baseline to 90-minutes after consumption of the beverage.
Glucose
Change from Baseline to 105-minutes after consumption of the beverage.
Glucose
Change from Baseline to 120-minutes after consumption of the beverage.
Insulin
Change from Baseline to 15-minutes after consumption of the beverage.
Insulin
Change from Baseline to 30-minutes after consumption of the beverage.
Insulin
Change from Baseline to 45-minutes after consumption of the beverage.
Insulin
Change from Baseline to 60-minutes after consumption of the beverage.
Insulin
Change from Baseline to 75-minutes after consumption of the beverage.
Insulin
Change from Baseline to 90-minutes after consumption of the beverage.
Insulin
Change from Baseline to 105-minutes after consumption of the beverage.
Insulin
Change from Baseline to 120-minutes after consumption of the beverage.
GLP-1
Change from Baseline to 15-minutes after consumption of the beverage.
GLP-1
Change from Baseline to 30-minutes after consumption of the beverage.
GLP-1
Change from Baseline to 45-minutes after consumption of the beverage.
GLP-1
Change from Baseline to 60-minutes after consumption of the beverage.
GLP-1
Change from Baseline to 75-minutes after consumption of the beverage.
GLP-1
Change from Baseline to 90-minutes after consumption of the beverage.
GLP-1
Change from Baseline to 105-minutes after consumption of the beverage.
GLP-1
Change from Baseline to 120-minutes after consumption of the beverage.
GIP
Change from Baseline to 15-minutes after consumption of the beverage.
GIP
Change from Baseline to 30-minutes after consumption of the beverage.
GIP
Change from Baseline to 45-minutes after consumption of the beverage.
GIP
Change from Baseline to 60-minutes after consumption of the beverage.
GIP
Change from Baseline to 75-minutes after consumption of the beverage.
GIP
Change from Baseline to 90-minutes after consumption of the beverage.
GIP
Change from Baseline to 105-minutes after consumption of the beverage.
GIP
Change from Baseline to 120-minutes after consumption of the beverage.
Secondary Outcomes (16)
Leptin
Change from Baseline to 60-minutes after consumption of the beverage.
Leptin
Change from Baseline to 120-minutes after consumption of the beverage.
Glucagon
Change from Baseline to 60-minutes after consumption of the beverage.
Glucagon
Change from Baseline to 120-minutes after consumption of the beverage.
Ghrelin
Change from Baseline to 60-minutes after consumption of the beverage.
- +11 more secondary outcomes
Study Arms (9)
First sub-study: Glucose beverage
ACTIVE COMPARATORThis intervention entails the intake of a beverage including 25 g of glucose.
First sub-study: Regular alcohol-free beer
EXPERIMENTALThis intervention entails the intake of regular alcohol-free beer including 25 of carbohydrates.
First sub-study: Alcohol-free beer with modified composition (isomaltulose + maltodextrin)
EXPERIMENTALThis intervention entails the intake of an alcohol-free beer with modified composition in which the maltose has been almost completely eliminated and enriched with isomaltulose (2.5 g/100 mL) and a resistant maltodextrin (0.8 g/100 mL) (IMB). This beverage included 25 g of carbohydrates.
First sub-study: Alcohol-free beer with modified composition (++ maltodextrin)
EXPERIMENTALThis intervention entails the intake of an alcohol-free beer with modified composition in which the maltose has been almost completely eliminated and enriched with a resistant maltodextrin (2.0 g/100 mL) (MB). This beverage included 25 g of carbohydrates.
Second sub-study: White bread + Water
ACTIVE COMPARATORThis intervention entails the intake of white bread (providing 50 g of carbohydrates) and water.
Second sub-study: White bread + Regular alcohol-free beer
EXPERIMENTALThis intervention entails the intake of white bread (providing 50 g of carbohydrates) and regular alcohol-free beer (providing 14.3 g of carbohydrates).
Second sub-study: White bread+Alcohol-free beer enriched with isomaltulose+maltodextrin)
EXPERIMENTALThis intervention entails the intake of white bread (providing 50 g of carbohydrates) and an alcohol-free beer with modified composition in which the maltose has been almost completely eliminated and enriched with isomaltulose (2.5 g/100 mL) and a resistant maltodextrin (0.8 g/100 mL) (IMB). This beverage included 14.3 g of carbohydrates.
Second sub-study: White bread + Alcohol-free beer enriched with ++ maltodextrin
EXPERIMENTALThis intervention entails the intake of white bread (providing 50 g of carbohydrates) and an alcohol-free beer with modified composition in which the maltose has been almost completely eliminated and enriched a resistant maltodextrin (2.0 g/100 mL) (MB). This beverage included 14.3 g of carbohydrates.
Second sub-study: Extra-White bread + Water
ACTIVE COMPARATORThis intervention entails the intake of white bread which provides 64.3 g (50 g + 14.3 g) of carbohydrates and water. This intervention would be the comparator in carbohydrates-equally conditions.
Interventions
Subjects were provided with: a) Glucose beverage; b) Regular alcohol-free beer; c) Alcohol-free beer with modified composition (isomaltulose + maltodextrin); d) Alcohol-free beer with modified composition (++ maltodextrin).
Subjects were provided with: a) White bread + Water; b) White bread + Regular alcohol-free beer; c) White bread+Alcohol-free beer enriched with isomaltulose+maltodextrin); d) White bread + Alcohol-free beer enriched with ++ maltodextrin; e) Extra-White bread + Water.
Eligibility Criteria
You may qualify if:
- BMI between 18.5 and 27.5 kg/m2.
You may not qualify if:
- Presence of cardiometabolic pathology such as dyslipemia (total cholesterol \> 200 mg/dL and/or triglycerides \> 150 mg/dL, and/or taking lipid-lowering drugs), prediabetes or type 1 or 2 diabetes mellitus (glucose ≥ 100 mg/dL and/or glycosylated hemoglobin ≥ 5.7% and/or taking hypoglycemic drugs) or high blood pressure without drug treatment.
- Presence of other chronic pathologies that could interfere with the results of the study such as cardiovascular disease, kidney disease, thyroid disease or liver disease.
- Presence of intestinal malabsorption syndromes and/or presence of Chron disease or ulcerative colitis.
- Use of drugs that may interfere with lipid and/or glycidic metabolism.
- Presence of some analytical alteration that could interfere with the results of the study.
- Increased or decreased body weight of ≥ 5 kg in the last 6 months.
- Gluten intolerance.
- Regular intake of functional foods such as phytosterols or red rice yeast, which have a significant effect on lipid or glycidic metabolism, in the last 6 weeks.
- Intake of vitamin supplements.
- Hormone replacement therapy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Universidad de Zaragozalead
- Instituto de Salud Carlos IIIcollaborator
Study Sites (1)
Instituto de Investigación Sanitaria Aragón, Hospital Universitario Miguel Servet, Universidad de Zaragoza
Zaragoza, 50009, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Masking Details
- The investigator who prepares the beverages and the bread is not blinded but the investigator who manage the samples and is plan to analyze the results is blinded.
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD
Study Record Dates
First Submitted
March 2, 2021
First Posted
March 10, 2021
Study Start
February 1, 2020
Primary Completion
December 31, 2020
Study Completion
March 30, 2021
Last Updated
September 30, 2021
Record last verified: 2021-09
Data Sharing
- IPD Sharing
- Will not share